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There is mounting evidence that autophagy is involved in di-
verse physiological and pathological processes that have im-
mense relevance in human development, diseases and aging. 
Immunity and inflammation are not exceptions. Here, the role 
of autophagy in the control of immune processes particularly 
that related to cell death and inflammation is discussed.
[Immune Network 2009;9(1):8-11]
INTRODUCTION
Macroautophagy (here referred to as autophagy) is a process 
of sequestration and removal of damaged organelles/proteins 
for recycling of their constituents and supply of nutrients. In 
addition, autophagy provides signals for the removal of apop-
totic cells and genomic stability (1). Hence, autophagy can 
be  generally  considered  as  a  protective  measure  for  cells 
against various types of injuries or from continuous cellular 
wear-and-tear.  The  physiological  role  of  autophagy  in  the 
mammalian system was demonstrated in several in vivo ani-
mal models. Disruption of autophagic processes leads to fail-
ure of cavitation during embryogenesis (2) or accumulation 
of abnormal mitochondria in adult tissues (3). In addition to 
the physiological roles, dysregulated autophagy has been sug-
gested to play pathogenic roles in a variety of disease proc-
esses including neurodegeneration (4,5) and cardiomyopathy 
(6) particularly when cellular stress is increased, which is like-
ly to be due to accumulation of damaged molecules and or-
ganelles  (6).  Other  studies  revealed  important  roles  for  au-
tophagy in tumor suppression (1) and ER stress responses (7).
AUTOPHAGY AND CELL DEATH
As discussed above, autophagy plays a protective role in di-
verse types of cellular stress. Paradoxically, autophagy can al-
so lead to a form of non-apoptotic cell death known as “type 
2 programmed cell death” (8-10) particularly when autophagy 
is excessive (11). Thus, the dual nature of autophagy can ei-
t h e r  p r o m o t e  c e l l  d e a t h  o r  p r o t e c t  c e l l s  f r o m  d i v e r s e  t y p e s 
of  injuries  depending  on  the  cellular  and  environmental 
context. In mice models that have a deficiency of autophagy 
specifically in neurons, increased apoptosis of neurons were 
observed (4,5). We and others have shown in mice with a 
pancreatic β-cell-specific deletion of an essential autophagy 
gene (Atg7 ) that the pancreatic β-cell mass was decreased 
due to increased pancreatic β-cell death and decreased β
-cell proliferation leading to a reduction of insulin production 
and  hyperglycemia  (12,13).  Large  intracellular  aggregates 
containing ubiquitin and p62 were observed in the pancreatic 
islets of β-cell-specific Atg7-null mice (13,14). However, in-
flammation  was  not  observed  but  in  the  case  of  hep-
atocyte-specific  Atg7-null  mice  it  was  observed  (data  not 
shown). Increased pancreatic β-cell death in β-cell-specific 
Atg7-null mice is consistent with previous data that suggests 
autophagy plays a protective role against cell injury and au-
tophagy-deficient cells would be susceptible to diverse types 
of cell death. Several potential mechanisms of increased sus-
ceptibility to cell death were proposed such as a shortage of 
bioenergetic sources like NADPH2 and ATP. The shortage of 
these sources may trigger apoptosis presumably through a di-
rect effect on the mitochondria or de-inhibit the activation of 
caspases or permeabilization of the mitochondrial outer mem-Role of Autophagy in the Control of Cell Death and Inflammation
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brane (15) or through activation of p27 by metabolic stress 
and energy deficiency that may also lead to cell cycle arrest 
and decreased proliferation (16). Modulation of mitochondrial 
mass or cytochrome c content by autophagy may be related 
to the changes in the susceptibility to apoptotic inducers (17). 
However, detailed mechanism of increased pancreatic β-cell 
death in β-cell-specific Atg7-null mice is unknown. Further-
more, it was suggested that the real process inhibited by au-
tophagy is necrosis rather than apoptosis which may be of 
relevance to the control of cell death-associated inflammation 
and  tumorigenesis  (18).
AUTOPHAGY, MACROPHAGE AND 
INFLAMMATION
Autophagy may also play a crucial role in the regulation of 
inflammation  and  immunity.  For  instance,  autophagy  has 
been reported to be critically involved in the eradication of 
microbes  such  as  Mycobacterium  tuberculosis ( 1 9 ) ,  a n t i g e n  
presentation  by  professional  antigen-presenting  cells  (APC) 
(20) and tolerance induction in T cells (21). Autophagy may 
also regulate inflammation or immunity by modulating surviv-
al  or  death  of  lymphocytes  (22)  and  APC  such  as 
macrophages. We have reported the role of ROS and STAT1 
in the necrotic death of macrophage by LPS in the presence 
of zVAD, a pan-caspase inhibitor (23). Then, a role for au-
tophagy in this type of macrophage death was reported. Xu 
et al. showed the death of macrophages by LPS in combina-
tion with zVAD had microscopic features of autophagy such 
as punctuate LC3 pattern and formation of autophagosomes 
surrounded by double membranes (24). Furthermore, Yu et 
al.  reported  that  autophagy  selectively  degraded  catalase 
leading to the accumulation of ROS and non-apoptotic death 
of macrophages (25). Contrary to those reports, a protective 
role of autophagy in macrophage death by zVAD was also 
reported (26). If zVAD is able to inhibit cathepsin and lysoso-
mal function as reported, then the apparent increased con-
version of LC3-I to LC3-II and the accumulation of autophago-
somes may be due to the blockade of autophagy at the lyso-
somal  step  rather  than  to  an  increased  autophagic  activity. 
Such a theory may provide a clue to the long-sought question 
regarding the additional target molecules of zVAD in addition 
to caspases. Thus, it is still unclear whether autophagy pro-
tects macrophages from death or induces macrophage death 
in  the  presence  of  zVAD.
    Autophagy  may  also  modulate  functions  of  macrophages 
in  addition  to  their  survival  or  death.  LC3  recruitment  was 
observed when macrophages ingested latex beads associated 
with TLR ligands, but not without TLR ligands (27). However, 
classical autophagosomes with double membranes were not 
observed in that case. Furthermore, microbes engulfed by au-
tophagy-deficient macrophages showed a marked survival ad-
vantage suggesting that TLR signaling may usurp the autopha-
gic machinery to deliver phagocytic material to the lysosomal 
pathway (27). TLR agonists themselves  have been reported 
to activate the autophagic pathway (28); however, a recent 
paper  reported  contradictory  results  (29).
AUTOPHAGY AND INFLAMMATORY/IMMUNE 
DISEASES
Besides in vitro or animal models, direct involvement of the 
autophagy-inflammation relationship in human diseases was 
recently reported. Crohn’s disease is characterized by chronic 
mucosal  or  transmural  inflammation  in  the  small  intestines 
particularly  in  the  distal  ileum.  Several  theories  have  been 
proposed related to the pathogenesis of Crohn’s disease such 
as mutations of NOD2, an important intracellular innate im-
mune receptor (30). Also several animal models are available 
for the study of Crohn’s disease. However, the detailed mo-
lecular  pathogenic  mechanism  is  still  far  from  clear. 
Large-scale genetic analysis revealed more than 30 loci show-
ing linkage to the disease development process (31). Among 
them, Atg16L1 locus is of particular interest because Atg16L1 
is a gene homolog to yeast Atg16, an essential gene for au-
tophagy  in  yeast.  Atg16L1  is  an  integral  component  of  the 
large molecular weight complex comprising Atg12-Atg5 con-
jugate and has been suggested to play an important role in 
the conjugation of LC3 (Atg8) to phosphatidylethanolamine. 
Thus, Atg16L1 has been regarded as a key gene that may pro-
v i d e  a  c l u e  t o  t h e  r e l a t i o n s h i p  b e t w e e n  a u t o p h a g y  a n d  i n-
flammation  in  human  diseases.  Indeed,  a  recent  paper 
showed a role of Atg16L1 in the control of inflammatory cyto-
kines from macrophages (29). Release of cytokines such as 
IL-1β and IL-18 after LPS or infection with non-invasive bac-
teria  such  as  E.  coli w a s  s i g n i f i c a n t l y  i n c r e a s e d  i n  
Atg16L1-null  macrophages.  Intriguingly,  IL-1β release  after 
infection with invasive bacteria such as Salmonella typhimu-
rium w a s  n o t  i n c r e a s e d  i n  Atg16L1-null  macrophages. 
Increased IL-1β or IL-18 secretion from Atg16L1-null macro-
phages appears to be due to increased ROS production induc-
ing  activation  of  caspase-1.  However,  the  molecular  details Role of Autophagy in the Control of Cell Death and Inflammation
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leading to the increase ROS production in autophagy-deficient 
macrophages  are  still  unknown.  Mice  lacking  Atg16L1  in 
hematopoietic cells did not show spontaneous colitis; how-
ever, they showed much severer colitis after dextran sulphate 
sodium (DSS) challenge. Another recent paper showed an ab-
normality in Paneth cells that are specialized cells in the in-
testinal  epithelium  secreting  antimicrobial  peptides  or  other 
intestinal  peptides  (32)  in  Atg16L1-deficient  mice  (33). 
Furthermore, production of adiponectin and leptin that mod-
ify  the  intestinal  environment  was  also  altered  in  autoph-
agy-deficient  Paneth  cells.
CONCLUSION
Autophagy appears to be critically involved in inflammation 
and immunity. So far, several pioneering studies have been 
done. Some of the results are not consistent with each other, 
which are more than likely due to an incomplete knowledge 
or misconception regarding the process of autophagy. For ex-
ample, it is becoming clear that autophagy level and autopha-
gic activity are not always the same, and the blockade of the 
autophagic process may be confused with increased autoph-
agy  due  to  the  possible  accumulation  of  autophagosomes. 
Thus, more thorough evaluation will be required for proper 
interpretation of future experimental findings and also for that 
of previously reported results. More investigations are being 
done and will be necessary to reveal the relationship between 
autophagy and the diverse types of inflammatory and (auto) 
immune disorders which will lead to the elucidation of hither-
to unknown and unsuspected aspects of both adaptive and 
innate  immunity.
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